Ovarian clear cell carcinoma-bad endometriosis or bad endometrium?

Journal of Pathology

Volumn 225, Issue 2, 2011, Pages 157-160

  Gounaris, Ioannis ^a,b   Charnock Jones, D Stephen ^b   Brenton, James D ^a,b  

^a CANCER RESEARCH UK CAMBRIDGE RESEARCH INSTITUTE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

ARID1A; endometrial carcinoma; endometriosis; ovarian clear cell carcinoma; PIK3CA

Indexed keywords

HEPATOCYTE NUCLEAR FACTOR 1BETA; INTERLEUKIN 6;

ARID1A GENE; CLEAR CELL CARCINOMA; CLINICAL PRACTICE; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; GENE; GENE MUTATION; HUMAN; OVARY; OVARY CARCINOMA; PATHOGENESIS; PELVIS; PIK3CA GENE; PRIORITY JOURNAL; REVIEW;

ADENOCARCINOMA, CLEAR CELL; ENDOMETRIOSIS; FEMALE; HUMANS; MUTATION; OVARIAN NEOPLASMS; PHOSPHATIDYLINOSITOL 3-KINASES; PRECANCEROUS CONDITIONS;

EID: 80052476886     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2970     Document Type: Review

References (20)

1. Sugiyama T, Kamura T, Kigawa J, et al., Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy. Cancer 2000; 88: 2584-2589. (Pubitemid 30331967)
2. Anglesio MS, Carey MS, Kobel M, et al., Clear cell carcinoma of the ovary: a report from the first Ovarian Clear Cell Symposium, June 24th, 2010. Gynecol Oncol 2011; 121: 407-415.
3. Ogawa S, Kaku T, Amada S, et al., Ovarian endometriosis associated with ovarian carcinoma: a clinicopathological and immunohistochemical study. Gynecol Oncol 2000; 77: 298-304. (Pubitemid 30317153)
4. Wiegand KC, Shah SP, Al-Agha OM, et al., ARID1A mutations in endometriosis-associated ovarian carcinomas. N Engl J Med 2010; 363: 1532-1543.
5. Jones S, Wang TL, Shih IM, et al., Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma. Science 2010; 330: 228-231.
6. Kuo KT, Mao T-L, Jones S, et al., Frequent activating mutations of PIK3CA in ovarian clear cell carcinoma. Am J Pathol 2009; 174: 1597-1601.
7. Yamamoto S, Tsuda H, Takano M, et al., PIK3CA mutation is an early event in the development of endometriosis-associated ovarian clear cell adenocarcinoma. J Pathol 2011; 225: 189-194.
8. Dunlap J, Le C, Shukla A, et al., Phosphatidylinositol-3-kinase and AKT1 mutations occur early in breast carcinoma. Breast Cancer Res Treat 2010; 120: 409-418.
9. Kato N, Sasou S, Motoyama T,. Expression of hepatocyte nuclear factor-1beta (HNF-1beta) in clear cell tumors and endometriosis of the ovary. Mod Pathol 2006; 19: 83-89. (Pubitemid 43250982)
10. Anglesio MS, George J, Kulbe H, et al., IL6-STAT3-HIF signaling and therapeutic response to the angiogenesis inhibitor sunitinib in ovarian clear cell cancer. Clin Cancer Res 2011; 17: 2538-2548.
11. Yamaguchi K, Mandai M, Oura T, et al., Identification of an ovarian clear cell carcinoma gene signature that reflects inherent disease biology and the carcinogenic processes. Oncogene 2010; 29: 1741-1752.
12. Bulun SE,. Endometriosis. N Engl J Med 2009; 360: 268-279.
13. Veras E, Mao T-L, Ayhan A, et al., Cystic and adenofibromatous clear cell carcinomas of the ovary. Distinctive tumors that differ in their pathogenesis and behavior: a clinicopathologic analysis of 122 cases. Am J Surg Pathol 2009; 33: 844-853.
14. Burney RO, Talbi S, Hamilton AE, et al., Gene expression analysis of endometrium reveals progesterone resistance and candidate susceptibility genes in women with endometriosis. Endocrinology 2007; 148: 3814-3826. (Pubitemid 47105847)
15. Yotova IY, Quan P, Leditznig N, et al., Abnormal activation of Ras/Raf/MAPK and RhoA/ROCKII signalling pathways in eutopic endometrial stromal cells of patients with endometriosis. Hum Reprod 2011; 26: 885-897.
16. Laudanski P, Szamatowicz J, Kowalczuk O, et al., Expression of selected tumor suppressor and oncogenes in endometrium of women with endometriosis. Hum Reprod 2009; 24: 1880-1890.
17. Martini M, Ciccarone M, Garganese G, et al., Possible involvement of hMLH1, p16(INK4a) and PTEN in the malignant transformation of endometriosis. Int J Cancer 2002; 102: 398-406. (Pubitemid 35265880)
18. Cheng C, Licence D, Cook E, et al., Activation of mutated K-ras in donor endometrial epithelium and stroma promotes lesion growth in an intact immunocompetent murine model of endometriosis. J Pathol 2011; 224: 261-269.
19. Wiegand KC, Lee AF, Al-Agha OM, et al., Loss of BAF250a (ARID1A) is frequent in high-grade endometrial carcinomas. J Pathol 2011; 224: 328-333.
20. Spurdle AB, Thompson DJ, Ahmed S, et al., Genome-wide association study identifies a common variant associated with risk of endometrial cancer. Nature Genet 2011; 43: 451-454.